The Treatment of Implant-retained Mandibular Overdentures for Edentulous Patients (TIMOEP)

April 18, 2020 updated by: Chufan Ma

A Clinical Trial on Conventional Dentures and Implant-retained Mandibular Overdentures With Respect to Oral Functionality and Quality of Life in Edentulous Patients

The purpose of this study is to investigate to what extent IOs improve the functionality of edentulous patients and changes in quality of life and overall patient satisfaction following treatment with IOs.

Study Overview

Status

Unknown

Conditions

Detailed Description

Edentulous individuals will be selected from patients attending the prosthodontic clinic. Then, new complete dentures will be provided; in a second stage half of these subjects (randomly selected) will receive IOs. The effect of different treatment protocols on chewing ability, patient satisfaction and OHRQoL will be investigated and assessed.

Study Type

Interventional

Enrollment (Anticipated)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shaanxi
      • Xi'an, Shaanxi, China, 710032
        • Recruiting
        • Department of Prosthodontics,School of Stomatology,The Fourth Military Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Being edentulous in the upper and lower jaw for at least 1 year
  2. Dissatisfied or cannot function with their complete lower denture
  3. Age between 40 and 75
  4. Suitable bone quality as assessed radiographically (CBCT) according to Zarb's classification。

Exclusion Criteria:

  1. Physical and mental disabilities which interfere with the maintenance of implants;
  2. Severe skeletal jaw discrepancies (class III)
  3. Those who have already received or lost dental implants
  4. Those who abuse drugs or alcohol
  5. Smoking more than 10 cigarettes a day
  6. Having received radiotherapy to the head and neck region for malignancies
  7. Undergoing chemotherapy
  8. On long-term therapy with steroids
  9. immunosuppressants or biphosphonates
  10. Insulin-dependent diabetic patients and uncontrolled onset diabetic patients
  11. Those affected by chronic renal or liver disease
  12. Systemic and local bone disorders and pathology
  13. Serious cardiac and pulmonary disorders
  14. Haemophilic disorders who are susceptible for increased bleeding and tendency for post-operative infections
  15. Those who are at risk of developing bacterial endocarditis
  16. Immune system compromised patients, including those with HIV

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: complete dentures
complete dentures will be provided for all subjects according to the standardized treatment protocol
Experimental: implant-retained overdentures
subjects will receive two-implant-retained overdentures in the mandible ,and continue wearing their complete denture in the maxilla
subjects will receive two-implant-retained overdentures in the mandible,and they continue wearing their complete denture in the maxilla.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
masticatory efficiency
Time Frame: three months after restoration of the implant-retained overdenture
masticatory efficiency will be measured with chwing-gum ,and the outcome will be analysed with the viewgum software
three months after restoration of the implant-retained overdenture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral health related quality of life
Time Frame: three months after restoration of the implant-retained overdenture
Oral health related quality of life will be measured with the Oral Health Impact Profile 14(OHIP-14).
three months after restoration of the implant-retained overdenture
patients' satisfaction
Time Frame: three months after restoration of the implant-retained overdenture
patients' satisfaction will be assessed on visual analog scales (VAS)
three months after restoration of the implant-retained overdenture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Chufan Ma, Air Force Military Medical University, China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

July 1, 2018

Study Completion (Anticipated)

April 1, 2020

Study Registration Dates

First Submitted

July 3, 2016

First Submitted That Met QC Criteria

July 26, 2016

First Posted (Estimate)

July 27, 2016

Study Record Updates

Last Update Posted (Actual)

April 21, 2020

Last Update Submitted That Met QC Criteria

April 18, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-REV-2016035

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

secret

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Edentulous

Clinical Trials on implant-retained overdentures

3
Subscribe